Year |
Citation |
Score |
2019 |
Knee KM, Jasuja R, Barakat A, Rao D, Wenzel Z, Sahasrabudhe P, Narula J, Jasti J, Chang JS, Beaumont K, Piotrowski DW, Janz JM. A Novel Non-Covalent Modulator of Hemoglobin Improves Anemia and Reduces Sickling in a Mouse Model of Sickle Cell Disease Blood. 134: 207-207. DOI: 10.1182/Blood-2019-128270 |
0.363 |
|
2015 |
King JA, Sergeeva O, Knee KM. How Do Group Ii Chaperonins Distinguish their Partially Folded Substrates from the Native States Biophysical Journal. 108. DOI: 10.1016/J.Bpj.2014.11.319 |
0.59 |
|
2015 |
Knee KM, Patel D, Sergeeva O, Kelly JJ, Janz JM, King JA, Yue W, Bulawa C. CCT5: A Model Protein Folding Machine Biophysical Journal. 108: 52a. DOI: 10.1016/J.Bpj.2014.11.318 |
0.576 |
|
2014 |
Sergeeva OA, Yang J, King JA, Knee KM. Group II archaeal chaperonin recognition of partially folded human γD-crystallin mutants. Protein Science : a Publication of the Protein Society. 23: 693-702. PMID 24615724 DOI: 10.1002/Pro.2452 |
0.58 |
|
2013 |
Knee KM, Sergeeva OA, King JA. Human TRiC complex purified from HeLa cells contains all eight CCT subunits and is active in vitro. Cell Stress & Chaperones. 18: 137-44. PMID 23011926 DOI: 10.1007/S12192-012-0357-Z |
0.55 |
|
2012 |
Pereira JH, Ralston CY, Douglas NR, Kumar R, Lopez T, McAndrew RP, Knee KM, King JA, Frydman J, Adams PD. Mechanism of nucleotide sensing in group II chaperonins. The Embo Journal. 31: 731-40. PMID 22193720 DOI: 10.1038/Emboj.2011.468 |
0.562 |
|
2012 |
Pereira JH, Ralston CY, Douglas NR, Kumar R, Lopez T, McAndrew RP, Knee KM, King JA, Frydman J, Adams PD. Mechanism of nucleotide sensing in group II chaperonins: Corrigendum The Embo Journal. 31: 3949-3950. DOI: 10.1038/Emboj.2012.245 |
0.46 |
|
2011 |
Goulet DR, Knee KM, King JA. Inhibition of unfolding and aggregation of lens protein human gamma D crystallin by sodium citrate. Experimental Eye Research. 93: 371-81. PMID 21600897 DOI: 10.1016/J.Exer.2011.04.011 |
0.578 |
|
2011 |
Ikuta T, Thatte HS, Tang JX, Mukerji I, Knee K, Bridges KR, Wang S, Montero-Huerta P, Joshi RM, Head CA. Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization. Archives of Biochemistry and Biophysics. 510: 53-61. PMID 21457702 DOI: 10.1016/J.Abb.2011.03.013 |
0.554 |
|
2011 |
Knee KM, Goulet DR, Zhang J, Chen B, Chiu W, King JA. The group II chaperonin Mm-Cpn binds and refolds human γD crystallin. Protein Science : a Publication of the Protein Society. 20: 30-41. PMID 20981710 DOI: 10.1002/Pro.531 |
0.6 |
|
2010 |
Pereira JH, Ralston CY, Douglas NR, Meyer D, Knee KM, Goulet DR, King JA, Frydman J, Adams PD. Crystal structures of a group II chaperonin reveal the open and closed states associated with the protein folding cycle. The Journal of Biological Chemistry. 285: 27958-66. PMID 20573955 DOI: 10.1074/Jbc.M110.125344 |
0.562 |
|
2010 |
Wang Y, Petty S, Trojanowski A, Knee K, Goulet D, Mukerji I, King J. Formation of amyloid fibrils in vitro from partially unfolded intermediates of human gammaC-crystallin. Investigative Ophthalmology & Visual Science. 51: 672-8. PMID 19684009 DOI: 10.1167/Iovs.09-3987 |
0.651 |
|
2010 |
Goulet DR, Knee KM, Mukerji I, King JA. Citrate Binding Stabilizes Human Gamma-Crystallin to Slow Unfolding and Inhibit Aggregation Biophysical Journal. 98: 614a. DOI: 10.1016/J.Bpj.2009.12.3350 |
0.682 |
|
2009 |
Knee KM, Mukerji I. Real time monitoring of sickle cell hemoglobin fiber formation by UV resonance Raman spectroscopy. Biochemistry. 48: 9903-11. PMID 19778007 DOI: 10.1021/Bi901352M |
0.593 |
|
2009 |
Knee KM, Goulet DR, Jameel S, King JA. Characterization of the Group II Chaperonin TriC derived from Human Cervical Adenocarcinoma (HeLa) Cells Biophysical Journal. 96. DOI: 10.1016/J.Bpj.2008.12.2221 |
0.608 |
|
2009 |
Goulet DR, King JA, Knee KM. Characterization of Substrate Binding to the Group II Archael Chaperonin from Methanococcus maripaludis (Mm-Cpn) Biophysical Journal. 96. DOI: 10.1016/J.Bpj.2008.12.2220 |
0.586 |
|
2008 |
Knee KM, Dixit SB, Aitken CE, Ponomarev S, Beveridge DL, Mukerji I. Spectroscopic and molecular dynamics evidence for a sequential mechanism for the A-to-B transition in DNA. Biophysical Journal. 95: 257-72. PMID 18326653 DOI: 10.1529/Biophysj.107.117606 |
0.551 |
|
2007 |
Knee KM, Roden CK, Flory MR, Mukerji I. The role of beta93 Cys in the inhibition of Hb S fiber formation. Biophysical Chemistry. 127: 181-93. PMID 17350155 DOI: 10.1016/J.Bpc.2007.02.002 |
0.599 |
|
Low-probability matches (unlikely to be authored by this person) |
2022 |
Kelly JJ, Tranter D, Pardon E, Chi G, Kramer H, Happonen L, Knee KM, Janz JM, Steyaert J, Bulawa C, Paavilainen VO, Huiskonen JT, Yue WW. Snapshots of actin and tubulin folding inside the TRiC chaperonin. Nature Structural & Molecular Biology. PMID 35449234 DOI: 10.1038/s41594-022-00755-1 |
0.299 |
|
2016 |
Knee KM, Jasuja R, Barakat A, Kelly JJ, Nneji JC, Singh P, Janz JM. Translation from SCD Mouse to Man: Chronic Administration of Tucaresol Reduces RBC Sickling and Improves Hematological Parameters, but Does Not Impact Inflammatory Markers in SCD Model Mice Blood. 128: 3644-3644. DOI: 10.1182/Blood.V128.22.3644.3644 |
0.295 |
|
2020 |
Gopalsamy A, Aulabaugh AE, Barakat A, Beaumont KC, Cabral S, Canterbury DP, Casimiro-Garcia A, Chang JS, Chen MZ, Choi C, Dow RL, Fadeyi OO, Feng X, France SP, Howard RM, ... ... Knee KM, et al. PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease. Journal of Medicinal Chemistry. PMID 33356244 DOI: 10.1021/acs.jmedchem.0c01518 |
0.166 |
|
2023 |
Barakat A, Jasuja R, Tomlinson L, Wenzel Z, Ramaiah L, Petterson BA, Kapinos B, Sawant A, Pagan V, Lintner N, Field D, Ahn Y, Knee KM. Effects of 2,3-DPG knockout on SCD phenotype in Townes SCD model mice. American Journal of Hematology. PMID 37688507 DOI: 10.1002/ajh.27082 |
0.125 |
|
2021 |
Knee KM, Jasuja R, Barakat A, Rao D, Wenzel Z, Jasti J, Novak J, Beaumont K, Piotrowski DW, Jeffrey P, Bulawa C, Murphy JE, Janz JM. PF-07059013: A Non-Covalent Hemoglobin Modulator Favorably Impacts Disease State in a Mouse Model of Sickle Cell Disease. American Journal of Hematology. PMID 33891711 DOI: 10.1002/ajh.26204 |
0.104 |
|
Hide low-probability matches. |